YWYeji Wang

Yeji Wang

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Yeji Wang has a total of 12 co-authors. Here are the top co-authors by number of shared publications:

  • Fujing Liu

    Department of Natural Product Chemistry, Key Laboratory of Chemical Biology (Ministry of Education), School of Pharmaceutical Sciences, Cheeloo College of Medicine, Shandong University, Jinan, Shandong Province, China

    1 shared publication
  • Gang Li

    Department of Natural Medicinal Chemistry and Pharmacognosy, School of Pharmacy, Qingdao University

    1 shared publication
  • Hong-Xiang Lou

    Shandong University

    1 shared publication
  • Huaizu Luan

    Department of Natural Product Chemistry, Key Laboratory of Chemical Biology (Ministry of Education), School of Pharmaceutical Sciences, Cheeloo College of Medicine, Shandong University, Jinan, Shandong Province, China

    1 shared publication
  • Minghui Song

    Department of Natural Product Chemistry, Key Laboratory of Chemical Biology (Ministry of Education), School of Pharmaceutical Sciences, Cheeloo College of Medicine, Shandong University, Jinan, Shandong Province, China

    1 shared publication
  • Rui Hong

    Department of Natural Product Chemistry, Key Laboratory of Chemical Biology (Ministry of Education), School of Pharmaceutical Sciences, Cheeloo College of Medicine, Shandong University, Jinan, Shandong Province, China

    1 shared publication

Latest Publications

  • Top Cited Papers
    Open Access

    Artificial intelligence using a latent diffusion model enables the generation of diverse and potent antimicrobial peptides

    by Yeji Wang, Minghui Song, Fujing Liu, Zhen Liang, Rui Hong, Yuemei Dong, Huaizu Luan, Xiaojie Fu, Wenchang Yuan, Wenjie Fang, et al.

    Artificial intelligence holds great promise for the design of antimicrobial peptides (AMPs); however, current models face limitations in generating AMPs with sufficient novelty and diversity, and they are rarely applied to the generation of antifungal peptides. Here, we develop an alternative pipeline grounded in a diffusion model and molecular dynamics for the de novo design of AMPs. The peptides generated by our pipeline have lower similarity and identity than those of other reported methodologies. Among the 40 peptides synthesized for an experimental validation, 25 exhibit either antibacterial or antifungal activity. AMP-29 shows selective antifungal activity against Candida glabrata and in vivo antifungal efficacy in a murine skin infection model. AMP-24 exhibits potent in vitro activity against Gram-negative bacteria and in vivo efficacy against both skin and lung Acinetobacter baumannii infection models. The proposed approach offers a pipeline for designing diverse AMPs to counteract the threat of antibiotic resistance.